📇 Rhumatologue · NANCY · (54) · Libéral
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Référence presse grand public
Cité 8 fois dans les médias — pédagogie reconnue
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
146.3 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CABINET DU DR MAXIME HOSOTTE
HOPITAL PRIVE NANCY LORRAINE 2 RUE MARIE MARVINGT, 54100 NANCY
CABINET DU DR MAXIME HOSOTTE
CENTRE D'ALLERGOLOGIE 10 RUE MI LES VIGNES, 54520 LAXOU
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 Le Republicain Lorrain · 09/04/2021
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxNWTg3bmxhMzJkTXcya3RyNmp4OHFwODdIQnMtOGp6WGl0SXZHXzMxVFNOVFptMU1mVlNyeHp5Sndod19aVVZDdDNSUGVfYjE4MWc1YjY2R2dzYUU2c2czWGRUV0tVUC1DcXBvTlVVRnhaYjJsNWIzbDhSbVUya3MtYUZmUWJUbGd0bE9LdU5USDVjakdnZW94a2dONTM0dGt2WXpXY0dEVlFSQQ?oc=5" target="_blan
📰 Elsan · 28/08/2025
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOa3J2d2VwWHVzVm90U1F1VjdSUnc4V2EwTUplZDFOd09kYWJJaVBWeWs1QzF0MmUwdWhwYTVXQUplZFhhbzA4N0V2S25LdzYzMTE2MG9IUkxzYWxyWTdTVHpNYnJfTHpiYjZsTm42V2l6bko2RG85R3JjcGNXdHRyNmg3cm5EdnZGQWdBQ1lHcTNfSGtTbndEaV9HTmJ2OFdKcTlkNTRMYVhEN0hfN2NSSzMxeHAxd2JVZ2
📰 Doctissimo · 08/04/2025
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQWXduVTZKZ2F1dUx5ZGxrdElFMWd0SnFlemp4MnNidGlGck9DVE1jRG5jdXdLTXlwNGl2Z1lLbzNSVXg2QmszY0NOdEJmbzU3bVJocUl0ZTZSajZhV19WR3VJZHczWW1nejJvdDA2UmlkSi1Mc2JpVkxEMzVxcWxqdU9GajJyYTZhTW55bkdyaHlua3prN04zVXhJUmVLSWVmYkdac3VaSmdnLWF3cEFkZC1rOWI?oc=5"
📰 France 3 Régions · 07/05/2024
<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxNQUdiX2lSaTIzNmZwU1NMTzlmMnAwMWZtVlNydFlyT21EWTRoZ1dHQXNpanhIRl9mMVo0RGlIb3NxNnQ2M05DQmM5Tnpxb2R4cF9aMk5pZDVwbjJXR01ZQmRvX0ZrVHlDM0pKTWpkRmdMV0tXTmR1SkVkY29jZFFhNlUwTjVxbVBvVk5qeHBDaEVzYVJqcHRMNHBzZzBhTEJuNFB3Nm9NenpCdW5ZVkFfMXpfNFAyQk43cn
📰 Top Santé · 18/07/2023
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxPM3BfUjN0LTNHOWl5MV9uYUhkUHd6M0NxeUpFdGVRX2txeFV6Rmg2QUdlRFliZFZ6cWhSbDhtZll6cTZEckRjWGxVMURkYzdOLVczZzdSTWdnN196dEYtcGl0V3o3UzF6cnZSZFRiRDd0d1JLcmxSbF9scUY1Z2RTTGhqMmdPcGhNcGNtRElmSXc?oc=5" target="_blank">Asthme : 6 idées reçues qu'il fa
📰 Magicmaman · 10/02/2023
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOMllGUkhmclViTEFpTHkyajFpek1PcHZobFRpMGdaWkNEYVZYVzZXX01kV3pjSXhIMUoybE1NRmtXZm5EZEdSTm1tWG4tdHdHeU5yYWpSSzVkNS1XN0lqUnhLek1ycG5BMVJyUDdZUndPQURNcHlob3Y4ZDZCNHpQTzJaY1Z2cldRRzRHU0h0TG1GWWs3S2FFckVYM24tZWh0ZWgxNnBkdV83ZElYQi01S2JOTjhyS3VGSX
📰 Doctissimo · 03/09/2020
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOaml5bUU3ZjlHc1pBVWN3SzFZZDRYNXNEX2psNnY0cThIUGI1SWdPZ3ZFRmRXTDdWbnpzRS16eDVPMS1MWEhrWndmMnUwbkZkWm5KQ3VxRW5fNlZLTnVSNjdNNGJ0TGFyNDVFRS0zUnhBNi1HUWZ3WEwySmU4SHJadjI0NlN0WFhHUFNuRzBPWkhqRlAwTmxXMGdEUGo4ZmlzNGRoREtHcS1Ydm1zb25Feng5MlRDZEpF?o
📰 France 3 Régions · 01/08/2024
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNSURBR0FLUEF5cnZBcklWYTNOOUlxYjBGT3ZKSFFwN1dFcktuQUNFZGcyQjgwQ0hSOHZqWU5CdGxRYkdveFVDMnZNejVmWWJoSzA4c05iNHNTVFlORXkxaDdqQ0tiTEhlX3JDczJnblJyRVYydGZaeHZ0dDVIbWFsNUkwN3BLeGdOc1NyNTREei1EY2hsM2kwSnVoemg0MlpIcG95bjhBWk9aZmNQc3JTMUlYbUdrUl9vQl
Frontiers in allergy · 2022
Sublingual allergen immunotherapy (SLIT) is a safe, effective, disease-modifying treatment for moderate-to-severe respiratory allergies. The function and responsiveness of the immune system components underlying the effects of allergen immunotherapy may vary from one patient to another. Furthermore, the severity of the symptoms of allergic disease can fluctuate over time, due to changes in environmental allergen exposure, effector cell responsiveness, and cell signaling. Hence, the allergen dose provided through SLIT can be fine-tuned to establish an optimal balance between effectiveness and tolerability. The objective of the MaDo study was to describe and understand dose adjustments of SLIT liquid formulations in France. We performed a retrospective, observational, cross-sectional, real-life study of allergists and other specialist physicians. Physicians described their patients via an anonymous case report form (CRF). The main patient inclusion criteria were age 5 years or over, at least one physician-confirmed IgE-driven respiratory allergy, and treatment for at least 2 years with one or more SLIT liquid preparations. A nationally representative sample of 33 specialist physicians participated in the study. The physicians' main stated reasons for dose adjustment were adverse events (according to 90.9% of the physicians), treatment effectiveness (60.6%), sensitivity to the allergen (42.4%) and other characteristics (30.3%: mainly symptom severity, type of allergen, and asthma). 392 CRFs (mean ± standard deviation patient age: 27.8 ± 17.5; under-18s: 42.1%; polyallergy: 30.9%) were analyzed. Respectively 53.6%, 25.8%, 15.3%, and 8.7% of the patients received house dust mite, grass pollen, birch pollen and cypress pollen SLIT. Dose adjustments were noted in 258 (65.8%) patients (at the start of the maintenance phase for 101 patients (39.2%) and later for 247 (95.7%)). Dose adjustment was not linked to sex, age, or the number of allergens administered. All measures of disease severity (including symptom severity noted on a 0-to-10 visual analogue scale by the physician) decreased significantly during SLIT. Notably, the mean AR symptom severity score decreased to a clinically relevant extent from 7.6 at SLIT initiation to 2.4 at last follow-up, and the mean asthma symptom severity score decreased from 5.0 to 1.3. The few differences in effectiveness between patients with vs. without dose adjustment were not major. For about one patient in five, a specialist physician decided to reduce or increase the SLIT liquid dose at the start of maintenance treatment and/or during maintenance treatment. This decision was influenced by a broad range of patient and treatment factors, mainly to improve tolerability to treatment and/or enhance effectiveness. In France, dose adjustment of SLIT liquid preparations as a function of the patient profile and/or treatment response is anchored in clinical practice. Precision dosing might optimize the overall benefit-risk profile of AIT for individual patients throughout their entire treatment course, enabling them to achieve both short- and long-term treatment goals, whilst maximizing the safety and tolerability.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Frontiers in allergy · 2022 · Journal Article
Thétis-Soulié M, Hosotte M, Grozelier I, Baillez C, et al.